EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

BRCA1 and BRCA2 mutations in breast and ovarian cancer families from south west Colombia

Laura Cifuentes-C iD, Ana Lucia Rivera-Herrera iD, Guillermo Barreto iD

Colombia Medica · 24.09.2019 · 50 (3) · 163-75

DOI: 10.25100/cm.v50i3.2385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colombia Medica, online erschienen am 24.09.2019. Verfasst von Laura Cifuentes-C und 2 weiteren Autor:innen. Beteiligte Einrichtung: Universidad del Valle, Departamento de Biología, Human Molecular Genetics Lab, Cali, Colombia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer is the most common neoplasia of women from all over the world especially women from Colombia. 5%­10% of all cases are caused by hereditary factors, 25% of those cases have mutations in the BRCA1/BRCA2 genes.

Objective

The purpose of this study was to identify the mutations associated with the risk of familial breast and/or ovarian cancer in a population of Colombian pacific.

Methods

58 high-risk breast and/or ovarian cancer families and 20 controls were screened for germline mutations in BRCA1 and BRCA2, by Single Strand Conformation Polymorphism (SSCP) and sequencing.

Results

Four families (6.9%) were found to carry BRCA1 mutations and eight families (13.8%) had mutations in BRCA2. In BRCA1, we found three Variants of Uncertain Significance (VUS), of which we concluded, using in silico tools, that c.81­12C>G and c.3119G>A (p.Ser1040Asn) are probably deleterious, and c.3083G>A (p.Arg1028His) is probably neutral. In BRCA2, we found three variants of uncertain significance: two were previously described and one novel mutation. Using in silico analysis, we concluded that c.865A>G (p.Asn289Asp) and c.6427T>C (p.Ser2143Pro) are probably deleterious and c.125A>G (p.Tyr42Cys) is probably neutral. Only one of them has previously been reported in Colombia. We also identified 13 polymorphisms (4 in BRCA1 and 9 in BRCA2), two of them are associated with a moderate increase in breast cancer risk (BRCA2 c.1114A>C and c.8755­66T>C).

Conclusion

According to our results, the Colombian pacific population presents diverse mutational spectrum for BRCA genes that differs from the findings in other regions in the country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCase-Control StudiesColombiaComputer SimulationFemaleGenetic Predisposition to DiseaseGerm-Line MutationHumansMiddle AgedOvarian NeoplasmsPolymorphism, Single-Stranded Conformational

Stichwörter der Autor:innen

BRCA1BRCA2ColombiaGerm-line mutationsHereditary Breast and Ovarian Cancer Syndrome

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Universidad del Valle, Departamento de Biología, Human Molecular Genetics Lab, Cali, Colombia.

ORCID-Profile: Laura Cifuentes-C, Ana Lucia Rivera-Herrera, Guillermo Barreto

Zitieren

APA

Cifuentes-C, L., Rivera-Herrera, A. L., & Barreto, G. (2019). BRCA1 and BRCA2 mutations in breast and ovarian cancer families from south west Colombia. Colombia Medica, 50(3), 163-75. https://doi.org/10.25100/cm.v50i3.2385

Vancouver

Cifuentes-C L, Rivera-Herrera AL, Barreto G. BRCA1 and BRCA2 mutations in breast and ovarian cancer families from south west Colombia. Colombia Medica. 2019;50(3):163-75. doi:10.25100/cm.v50i3.2385

BibTeX
@article{CifuentesC2019,
  author = {Cifuentes-C, Laura and Rivera-Herrera, Ana Lucia and Barreto, Guillermo},
  title = {BRCA1 and BRCA2 mutations in breast and ovarian cancer families from south west Colombia},
  journal = {Colombia Medica},
  year = {2019},
  volume = {50},
  number = {3},
  pages = {163--75},
  doi = {10.25100/cm.v50i3.2385}
}
Kostenlos starten →